Search Results - "Valensi, P."

1-h post-load plasma glucose for detecting early stages of prediabetes by Buysschaert, M., Bergman, M., Valensi, P.

“…Prediabetes is a very prevalent condition associated with an increased risk of developing diabetes and/or other chronic complications, in particular…”
Get full text

High Fasting Plasma Glucose during Early Pregnancy: A Review about Early Gestational Diabetes Mellitus by Cosson, Emmanuel, Valensi, Paul, Carbillon, L.

“…Fasting plasma glucose (FPG) is nowadays routinely measured during early pregnancy to detect preexisting diabetes (FPG ≥ 7 mmol/L). This screening has…”
Get full text

Congestive heart failure caused by silent ischemia and silent myocardial infarction: Diagnostic challenge in type 2 diabetes by Valensi, P., Meune, C.

“…In asymptomatic patients with type 2 diabetes (T2D), the prevalence of silent myocardial infarction on routine electrocardiograms is about 4% while for silent…”
Get full text

Type 2 diabetes: Why should diabetologists and cardiologists work more closely together? by Valensi, P., Picard, S., Pathak, A.

Get full text

Insulin- and glucagon-like peptide-1-induced changes in heart rate and vagosympathetic activity: why they matter by Valensi, P., Chiheb, S., Fysekidis, M.

“…Heart rate (HR) predicts cardiovascular morbidity and mortality in individuals either with or without diabetes. In type 2 diabetic patients, cardiac autonomic…”
Get full text

SEVERE REFRACTORY HYPOTHYROIDISM IN A 48-YEAR-OLD FEMALE: ROLE OF LOW-DOSE THYROXINE ABSORPTION TEST IN ESTABLISHING DIAGNOSIS OF NONCOMPLIANCE by Younes, N, Pinto, S, Valensi, P

“…A 48-year-old female presented with severe chronic hypothyroidism despite progressively increasing doses of levothyroxine. Poor adherence was suspected based…”
Get full text

Findrisk score, pulse wave velocity and detecting dysglycemia in a risk population of diabetes by Belhadj-Mostefa, A, Valensi, P

“…Introduction and aim Findrisk score has been validated for prediction of diabetes risk in many populations. The aim of this study was to examine the value of…”
Get full text

Welcome to the 9th Annual meeting of the Diabetes & Cardiovascular disease by Valensi, P, Ceriello, A

Get full text

Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement by Cosson, E., Catargi, B., Cheisson, G., Jacqueminet, S., Ichai, C., Leguerrier, A.-M., Ouattara, A., Tauveron, I., Bismuth, E., Benhamou, D., Valensi, P.

Get full text

Performance of a selective screening strategy for diagnosis of hyperglycaemia in pregnancy as defined by IADPSG/WHO criteria by Cosson, E., Vicaut, E., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Baudry, C., Cussac-Pillegand, C., Costeniuc, D., Valensi, P., Carbillon, L.

“…Our study evaluated the performance of a selective screening strategy for hyperglycaemia in pregnancy (HIP) based on the presence of risk factors (RFs; body…”
Get full text

Pregnancy adverse outcomes related to pregravid body mass index and gestational weight gain, according to the presence or not of gestational diabetes mellitus: A retrospective observational study by Cosson, E, Cussac-Pillegand, C, Benbara, A, Pharisien, I, Nguyen, M.T, Chiheb, S, Valensi, P, Carbillon, L

“…Abstract Aim This study retrospectively evaluated the complications associated with prepregnancy overweight (OW) or obesity (OB) and gestational weight gain…”
Get full text

Frequency-modulated electromagnetic neural stimulation (FREMS) as a treatment for symptomatic diabetic neuropathy: results from a double-blind, randomised, multicentre, long-term, placebo-controlled clinical trial by Bosi, E., Bax, G., Scionti, L., Spallone, V., Tesfaye, S., Valensi, P., Ziegler, D.

“…Aims/hypothesis The aim was to evaluate the efficacy and safety of transcutaneous frequency-modulated electromagnetic neural stimulation (frequency rhythmic…”
Get full text

Early screening for gestational diabetes mellitus is not associated with improved pregnancy outcomes: an observational study including 9795 women by Cosson, E., Vicaut, E., Sandre-Banon, D., Gary, F., Pharisien, I., Portal, J.-J., Banu, I., Bianchi, L., Cussac-Pillegand, C., Dina, R., Chiheb, S., Valensi, P., Carbillon, L.

“…In addition to screening for hyperglycaemia during pregnancy after 24 weeks of gestation (WG), the current guidelines also suggest screening in early pregnancy…”
Get full text

Prognosis associated with initial care of increased fasting glucose in early pregnancy: A retrospective study by Cosson, E., Vicaut, E., Berkane, N., Cianganu, T.L., Baudry, C., Portal, J.-J., Boujenah, J., Valensi, P., Carbillon, L.

“…To evaluate whether the initial care of women with fasting plasma glucose (FPG) levels at 5.1–6.9mmol/L before 22 weeks of gestation (WG), termed ‘early…”
Get full text

Initially untreated fasting hyperglycaemia in early pregnancy: prognosis according to occurrence of gestational diabetes mellitus after 22 weeks’ gestation: a case–control study by Cosson, E., Vicaut, E., Sandre‐Banon, D., Gary, F., Pharisien, I., Portal, J.‐J., Baudry, C., Cussac‐Pillegand, C., Valensi, P., Carbillon, L.

“…Aims To evaluate the percentage of women with untreated fasting hyperglycaemia in early pregnancy who develop gestational diabetes mellitus after 22 weeks’…”
Get full text

Metabolic syndrome in adolescents: definition based on regression of IDF adult cut-off points by Benmohammed, K, Valensi, P, Balkau, B, Lezzar, A

“…Abstract Objectives The objective of this study was to derive a sex- and age-specific definition of the metabolic syndrome (MetS) and its abnormalities for…”
Get full text

Screening for dysglycaemia during pregnancy: Proposals conciliating International Association of Diabetes and Pregnancy Study Group (IADPSG) and US National Institutes of Health (NIH) panels by Cosson, E, Valensi, P, Carbillon, L

“…Abstract The International Association of Diabetes and Pregnancy Study Group (IADPSG) has proposed that blood glucose levels for the diagnosis of gestational…”
Get full text

Improving postpartum glucose screening after gestational diabetes mellitus: a cohort study to evaluate the multicentre IMPACT initiative by Cosson, E., Bihan, H., Vittaz, L., Khiter, C., Carbillon, L., Faghfouri, F., Leboeuf, D., Dauphin, H., Lepagnol, A., Reach, G., Valensi, P.

“…Aims To evaluate a mobilization campaign, the IMPACT initiative, which included multidisciplinary meetings, provision of information and a systematic…”
Get full text

Cetilistat (ATL-962), a novel lipase inhibitor: a 12-week randomized, placebo-controlled study of weight reduction in obese patients by Kopelman, P, Bryson, A, Hickling, R, Rissanen, A, Rossner, S, Toubro, S, Valensi, P

“…Objective: To determine the efficacy, safety and tolerability of cetilistat (ATL-962), a novel inhibitor of gastrointestinal (GI) lipases, in obese patients…”
Get full text

A simple new non-invasive sweat indicator test for the diagnosis of diabetic neuropathy by Papanas, N., Boulton, A. J. M., Malik, R. A., Manes, C., Schnell, O., Spallone, V., Tentolouris, N., Tesfaye, S., Valensi, P., Ziegler, D., Kempler, P.

“…A simple non‐invasive indicator test (Neuropad®) has been developed for the assessment of sweating and, hence, cholinergic innervation in the diabetic foot…”
Get full text